SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Maurer Florian P.)
 

Sökning: WFRF:(Maurer Florian P.) > (2022) > Emergence of bedaqu...

Emergence of bedaquiline resistance in a high tuberculosis burden country

Chesov, Elena (författare)
Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Moldova; Chiril Draganiuc Phthisiopneumology Institute, Chisinau, Moldova; German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany; Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany
Chesov, Dumitru (författare)
Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Moldova; German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany; Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany
Maurer, Florian P. (författare)
National and Supranational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany; Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
visa fler...
Andres, Sönke (författare)
National and Supranational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany
Utpatel, Christian (författare)
Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany
Barilar, Ivan (författare)
Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany
Donica, Ana (författare)
Chiril Draganiuc Phthisiopneumology Institute, Chisinau, Moldova
Reimann, Maja (författare)
German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany; Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany; Respiratory Medicine & International Health, University of Lübeck, Lübeck, Germany
Niemann, Stefan (författare)
German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany; National and Supranational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany
Lange, Christoph (författare)
Umeå universitet,Avdelningen för medicin,Chiril Draganiuc Phthisiopneumology Institute, Chisinau, Moldova; German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany; Respiratory Medicine & International Health, University of Lübeck, Lübeck, Germany; Global TB Program, Baylor College of Medicine, Texas Children’s Hospital, TX, Houston, United States
Crudu, Valeriu (författare)
Chiril Draganiuc Phthisiopneumology Institute, Chisinau, Moldova
Heyckendorf, Jan (författare)
German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany; Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany; Respiratory Medicine & International Health, University of Lübeck, Lübeck, Germany
Merker, Matthias (författare)
German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany; Evolution of the Resistome, Research Center Borstel, Borstel, Germany
visa färre...
 (creator_code:org_t)
2021-09-09
2022
Engelska.
Ingår i: European Respiratory Journal. - : European Respiratory Society. - 0903-1936 .- 1399-3003. ; 59:3
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Rationale: Bedaquiline has been classified as a group A drug for the treatment of multidrug-resistant tuberculosis (MDR-TB) by the World Health Organization; however, globally emerging resistance threatens the effectivity of novel MDR-TB treatment regimens.Objectives: We analysed pre-existing and emerging bedaquiline resistance in bedaquiline-based MDR-TB therapies, and risk factors associated with treatment failure and death.Methods: In a cross-sectional cohort study, we employed patient data, whole-genome sequencing (WGS) and phenotyping of Mycobacterium tuberculosis complex (MTBC) isolates. We could retrieve baseline isolates from 30.5% (62 out of 203) of all MDR-TB patients who received bedaquiline between 2016 and 2018 in the Republic of Moldova. This includes 26 patients for whom we could also retrieve a follow-up isolate.Measurements and main results: At baseline, all MTBC isolates were susceptible to bedaquiline. Among 26 patients with available baseline and follow-up isolates, four (15.3%) patients harboured strains which acquired bedaquiline resistance under therapy, while one (3.8%) patient was re-infected with a second bedaquiline-resistant strain. Treatment failure and death were associated with cavitary disease (p=0.011), and any additional drug prescribed in the bedaquiline-containing regimen with WGS-predicted resistance at baseline (OR 1.92 per unit increase, 95% CI 1.15–3.21; p=0.012).Conclusions: MDR-TB treatments based on bedaquiline require a functional background regimen to achieve high cure rates and to prevent the evolution of bedaquiline resistance. Novel MDR-TB therapies with bedaquiline require timely and comprehensive drug resistance monitoring.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Mikrobiologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Microbiology in the medical area (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy